-
1تقرير
المصدر: PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/Ib Platform Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05868226Test
-
2تقرير
المؤلفون: Jiangsu HengRui Medicine Co., Ltd.
المصدر: An Open-label, Phase 2 Study of Pyrotinib Maleate in Advanced Solid Tumors Patients With HER2( Erb-B2 Receptor Tyrosine Kinase 2)-Postive
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04179656Test
-
3تقرير
المصدر: A Phase 1 Study of an Autologous ACTR T Cell Product in Combination With Trastuzumab, a Monoclonal Antibody, in Subjects With HER2-Positive Advanced Malignancies
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03680560Test
Other URLs: https://www.unumrx.comTest/
-
4تقرير
المصدر: Long-Term Follow-Up Study of Subjects Treated With an Autologous T Cell Product Expressing an Antibody-Coupled T-Cell Receptor (ACTR)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02840110Test
